Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial
scientific article published on 29 December 2012
Author/s
author: Barbara Pro, Luis E. Fayad, Michelle A Fanale, Jason R Westin, Nathan H Fowler, Larry Kwak, Fredrick B Hagemeister, Peter J McLaughlin, Jorge Romaguera, Felipe Samaniego, Wenli Dong
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.